Reports by quarter

Reports submitted in 2026-Q3 · page 12

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.93 % area, n=455. Read the 2026-Q3 state-of-the-index report →

455 records12 pagesmedian on this page 97.98 %updated 30 Jul 2026

Report	Compound	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-041979	Tirzepatide	AMB	AMB-2603-C5112	Janoshik	2026-Q3	97.48	3.86	90.8	Buyer-sourced	0	PASS
AX-2026-041330	Semaglutide	WWB	WWB-2606-N3192	PeptideMeter	2026-Q3	99.30	4.11	103.5	Buyer-sourced	0	PASS
AX-2026-043091	Retatrutide	KP	KP-2607-H5774	Janoshik	2026-Q3	96.13	5.94	—	Buyer-sourced	0	FAIL
AX-2026-041783	Retatrutide	ASY	ASY-{CAT}-2288	Kestrel	2026-Q3	99.44	6.46	101.4	Buyer-sourced	0	PASS
AX-2026-041332	Semaglutide	WWB	WWB-2606-N3192	Janoshik	2026-Q3	99.12	4.37	88.7	Buyer-sourced	1	MARGINAL
AX-2026-043296	Liraglutide	CPC	CPC-2602-G9942	Janoshik	2026-Q3	97.13	5.10	100.1	Buyer-sourced	0	FAIL
AX-2026-041927	IGF-1 LR3	SinoPep	SNP-2606-D4620	Janoshik	2026-Q3	98.48	5.63	96.9	Buyer-sourced	1	MARGINAL
AX-2026-043373	Semaglutide	WXT	WXT-2604-C3248	Janoshik	2026-Q3	97.34	3.91	103.4	Supplier-supplied	1	MARGINAL
AX-2026-043293	Liraglutide	CPC	CPC-2602-G9942	Janoshik	2026-Q3	97.98	5.22	94.5	Supplier-supplied	0	PASS
AX-2026-043093	Retatrutide	KP	KP-2607-H5774	Janoshik	2026-Q3	96.54	5.54	—	Buyer-sourced	0	PASS
AX-2026-043092	Retatrutide	KP	KP-2607-H5774	Medutest	2026-Q3	96.64	6.12	—	Buyer-sourced	1	FAIL
AX-2026-042234	Humanin (HNG)	TFC	TFC-2608-S9940	Janoshik	2026-Q3	98.37	2.39	—	Buyer-sourced	0	PASS
AX-2026-042523	Semax	Homopeptide	HOMO-2605-S5227	PeptideMeter	2026-Q3	99.93	6.00	96.9	Supplier-supplied	0	PASS
AX-2026-042506	IGF-1 LR3	Homopeptide	HOMO-2607-P5131	PeptideMeter	2026-Q3	98.58	6.21	—	Buyer-sourced	0	PASS
AX-2026-041980	Tirzepatide	AMB	AMB-2603-C5112	Janoshik	2026-Q3	97.89	4.16	102.3	Buyer-sourced	0	PASS